NASDAQ : ATHE
Alterity Therapeutics Limited — Financial statements
Healthcare · Biotechnology · Australia
Last price 2.2335 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 41.92M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Alterity Therapeutics Limited (ATHE) reported revenue of 3.61M AUD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Other Revenue | 3.61M | 3.61M | 5.44M | 4.02M | 3.92M | 5.12M |
| Revenue | 3.61M | 3.61M | 5.44M | 4.02M | 3.92M | 5.12M |
| Cost of Revenue | 262.78K | 262.78K | 127.52K | 214.30K | 285.07K | 364.67K |
| Gross Profit | 3.35M | 3.35M | 5.31M | 3.80M | 3.63M | 4.76M |
| Selling, General & Admin | 10.53M | 10.53M | 5.48M | 4.76M | 5.06M | 5.51M |
| Research & Development | 17.63M | 17.63M | 14.40M | 18.64M | 13.20M | 14.75M |
| Other Operating Expenses | 283.88K | 283.88K | 87.27K | 5.24K | 29.40K | 1.16K |
| Operating Expenses | 28.44M | 28.44M | 19.97M | 23.41M | 18.27M | 20.26M |
| Operating Income | -25.09M | -25.09M | -14.66M | -19.61M | -14.64M | -15.50M |
| Interest & Investment Income | 1.72M | 1.72M | 446.29K | 268.42K | 16.44K | 2.50K |
| Currency Exchange Gain (Loss) | 90.12K | 90.12K | 259.43K | 261.15K | 917.65K | 2.72M |
| Other Non Operating Income (Expenses) | -326.54K | |||||
| EBT Excluding Unusual Items | -23.29M | -23.29M | -14.28M | -19.08M | -13.70M | -12.78M |
| Other Unusual Items | 1.98M | |||||
| Pretax Income | -23.29M | -23.29M | -12.08M | -19.08M | -13.70M | -12.78M |
| Income Tax Expense | 113.50K | 113.50K | 68.06K | 46.09K | 104.46K | 70.01K |
| Net Income | -23.40M | -23.40M | -12.15M | -19.12M | -13.81M | -12.85M |
| Net Income to Common | -23.40M | -23.40M | -12.15M | -19.12M | -13.81M | -12.85M |
| Shares Outstanding (Basic) | 210.49M | 210.49M | 127.94M | 72.98M | 48.56M | 48.12M |
| Shares Outstanding (Diluted) | 210.49M | 210.49M | 127.94M | 72.98M | 48.56M | 48.12M |
| EPS (Basic) | -0.11 | -0.11 | -0.09 | -0.26 | -0.28 | -0.27 |
| EPS (Diluted) | -0.11 | -0.11 | -0.09 | -0.26 | -0.28 | -0.27 |
| Free Cash Flow | -22.52M | -22.52M | -11.45M | -12.61M | -20.04M | -12.43M |
| Free Cash Flow Per Share | -0.11 | -0.11 | -0.09 | -0.17 | -0.41 | -0.26 |
| Gross Margin | 92.72% | 92.72% | 97.66% | 94.67% | 92.72% | 92.88% |
| Operating Margin | -695.13% | -695.13% | -269.57% | -487.82% | -373.72% | -302.56% |
| Profit Margin | -648.22% | -648.22% | -223.35% | -475.79% | -352.54% | -250.75% |
| Free Cash Flow Margin | -623.91% | -623.91% | -210.54% | -313.78% | -511.78% | -242.54% |
| EBITDA | -25.09M | -25.09M | -14.63M | -19.57M | -14.60M | -15.48M |
| EBITDA Margin | -269.05% | |||||
| D&A For EBITDA | 3.55K | 3.55K | 28.31K | 35.34K | 37.85K | 17.85K |
| EBIT | -25.09M | -25.09M | -14.66M | -19.61M | -14.64M | -15.50M |
| EBIT Margin | -269.57% |
Balance sheet
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 37.32M | 37.32M | 33.16M | 12.64M | 15.77M | 34.81M |
| Short-Term Investments | 7.50M | |||||
| Cash & Short-Term Investments | 37.32M | 37.32M | 40.66M | 12.64M | 15.77M | 34.81M |
| Accounts Receivable | 7.54M | 7.54M | 3.93M | 4.02M | 8.65M | 4.67M |
| Other Receivables | 160.58K | 160.58K | 9.04K | 22.39K | 16.84K | 55.96K |
| Receivables | 7.70M | 7.70M | 3.94M | 4.04M | 8.67M | 4.73M |
| Prepaid Expenses | 768.99K | 768.99K | 1.23M | 2.32M | 2.57M | 1.60M |
| Other Current Assets | 42.79K | 42.79K | 41.81K | 40.67K | 39.76K | 10.23K |
| Total Current Assets | 45.83M | 45.83M | 45.87M | 19.04M | 27.05M | 41.14M |
| Property, Plant & Equipment | 190.56K | 190.56K | 155.17K | 186.88K | 268.86K | 218.52K |
| Total Assets | 46.02M | 46.02M | 46.03M | 19.22M | 27.32M | 41.36M |
| Accounts Payable | 1.12M | 1.12M | 538.28K | 581.14K | 1.72M | 2.66M |
| Accrued Expenses | 1.92M | 1.92M | 2.89M | 4.56M | 2.50M | 3.02M |
| Current Portion of Leases | 55.17K | 55.17K | 66.91K | 107.13K | 107.18K | 57.63K |
| Current Income Taxes Payable | 48.44K | 48.44K | 16.28K | 15.99K | 27.93K | 26.92K |
| Other Current Liabilities | 17.16K | 17.16K | 19.39K | 114.43K | 33.91K | 57.62K |
| Total Current Liabilities | 3.16M | 3.16M | 3.53M | 5.37M | 4.38M | 5.82M |
| Long-Term Leases | 138.29K | 138.29K | 88.55K | 51.91K | 103.21K | 59.86K |
| Other Long-Term Liabilities | -1.00 | 19.50K | 13.75K | |||
| Total Liabilities | 3.29M | 3.29M | 3.62M | 5.43M | 4.50M | 5.89M |
| Common Stock | 282.51M | 282.51M | 262.95M | 223.15M | 213.97M | 213.79M |
| Retained Earnings | -245.58M | -245.58M | -225.89M | -214.16M | -195.13M | -181.88M |
| Comprehensive Income & Other | 5.80M | 5.80M | 5.34M | 4.81M | 3.97M | 3.57M |
| Shareholders' Equity | 42.72M | 42.72M | 42.40M | 13.80M | 22.81M | 35.47M |
| Total Liabilities & Equity | 46.02M | 46.02M | 46.03M | 19.22M | 27.32M | 41.36M |
| Total Debt | 193.47K | 193.47K | 155.46K | 159.04K | 210.38K | 117.49K |
| Net Cash (Debt) | 37.12M | 37.12M | 40.50M | 12.48M | 15.56M | 34.69M |
| Net Cash Per Share | 0.18 | 0.18 | 0.32 | 0.17 | 0.32 | 0.72 |
| Filing Date Shares Outstanding | 218.50M | 218.50M | 184.17M | 106.41M | 48.80M | 48.14M |
| Total Common Shares Outstanding | 217.51M | 217.51M | 182.55M | 104.90M | 48.80M | 48.14M |
| Working Capital | 42.67M | 42.67M | 42.34M | 13.66M | 22.67M | 35.32M |
| Book Value Per Share | 0.20 | 0.20 | 0.23 | 0.13 | 0.47 | 0.74 |
| Tangible Book Value | 42.72M | 42.72M | 42.40M | 13.80M | 22.81M | 35.47M |
| Tangible Book Value Per Share | 0.20 | 0.20 | 0.23 | 0.13 | 0.47 | 0.74 |
Cash flow statement
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -23.40M | -23.40M | -12.15M | -19.12M | -13.81M | -12.85M |
| Depreciation & Amortization | 115.54K | 115.54K | 139.72K | 147.53K | 102.26K | 54.21K |
| Asset Writedown & Restructuring Costs | 10.23K | |||||
| Stock-Based Compensation | 4.49M | 4.49M | 979.92K | 881.95K | 966.57K | 1.51M |
| Other Operating Activities | -33.61K | -33.61K | 190.62K | -261.15K | -917.65K | -2.81M |
| Change in Accounts Receivable | -3.76M | -3.76M | 104.07K | 4.62M | -3.94M | -447.68K |
| Change in Accounts Payable | -549.24K | -549.24K | -2.04M | 1.10M | -1.56M | 2.60M |
| Change in Other Net Operating Assets | 613.46K | 613.46K | 1.33M | 23.05K | -889.52K | -393.29K |
| Operating Cash Flow | -22.52M | -22.52M | -11.45M | -12.61M | -20.04M | -12.34M |
| Capital Expenditures | -5.72K | -7.31K | -89.15K | |||
| Investment in Securities | 7.50M | 7.50M | -7.50M | |||
| Other Investing Activities | -29.15K | |||||
| Investing Cash Flow | 7.50M | 7.50M | -7.50M | -5.72K | -36.46K | -89.15K |
| Long-Term Debt Repaid | -136.56K | -136.56K | -127.10K | -10.37K | -59.92K | -34.51K |
| Lease Payments | -136.56K | -136.56K | -127.10K | -10.37K | -59.92K | -34.51K |
| Net Debt Issued (Repaid) | -136.56K | -136.56K | -127.10K | -10.37K | -59.92K | -34.51K |
| Issuance of Common Stock | 20.38M | 20.38M | 42.57M | 10.14M | 316.68K | 17.18M |
| Other Financing Activities | -1.11M | -1.11M | -2.77M | -918.02K | -132.41K | -836.97K |
| Financing Cash Flow | 19.13M | 19.13M | 39.67M | 9.22M | 124.34K | 16.30M |
| Foreign Exchange Rate Adjustments | 51.57K | 51.57K | -198.38K | 260.36K | 914.94K | 2.81M |
| Net Cash Flow | 4.16M | 4.16M | 20.52M | -3.13M | -19.03M | 6.69M |
| Free Cash Flow | -22.52M | -22.52M | -11.45M | -12.61M | -20.04M | -12.43M |
| Free Cash Flow Margin | -623.91% | -623.91% | -210.54% | -313.78% | -511.78% | -242.54% |
| Free Cash Flow Per Share | -0.11 | -0.11 | -0.09 | -0.17 | -0.41 | -0.26 |
| Levered Free Cash Flow | -14.74M | -14.74M | -8.66M | -5.36M | -14.53M | -6.46M |
| Unlevered Free Cash Flow | -14.74M | -14.74M | -8.66M | -5.36M | -14.53M | -6.46M |
| Free Cash Flow After Leases | -22.66M | -22.66M | -11.58M | -12.62M | -20.10M | -12.46M |
| Cash Interest Paid | 7.22K | 4.57K | 2.29K | |||
| Cash Income Tax Paid | 81.34K | 81.34K | -5.56M | -8.53M | 103.45K | -4.08M |
| Change in Working Capital | -3.70M | -3.70M | -613.68K | 5.75M | -6.39M | 1.76M |
Ratios
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 42.71M | 86.52M | 59.84M | 14.00M | 11.37M | 21.56M |
| Enterprise Value | 16.59M | 52.55M | 56.94M | 5.95M | -5.44M | -3.91M |
| Last Close Price | 2.16 | 5.37 | 4.09 | 1.81 | 2.79 | 6.11 |
| PS Ratio | 17.10 | 34.65 | 16.78 | 5.22 | 4.36 | 6.11 |
| PB Ratio | 1.45 | 2.93 | 2.15 | 1.52 | 0.75 | 0.88 |
| P/TBV Ratio | 1.45 | 2.93 | 2.15 | 1.52 | 0.75 | 0.88 |
| EV/Sales Ratio | 6.64 | 21.04 | 15.97 | 2.22 | ||
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 |
| Net Debt / Equity Ratio | -0.87 | -0.87 | -0.95 | -0.90 | -0.68 | -0.98 |
| Net Debt / EBITDA Ratio | 1.48 | 1.48 | 2.77 | 0.64 | 1.07 | 2.24 |
| Net Debt / FCF Ratio | 1.65 | 1.65 | 3.54 | 0.99 | 0.78 | 2.79 |
| Asset Turnover | 0.08 | 0.08 | 0.17 | 0.17 | 0.11 | 0.14 |
| Quick Ratio | 14.26 | 14.26 | 12.62 | 3.10 | 5.58 | 6.79 |
| Current Ratio | 14.52 | 14.52 | 12.98 | 3.54 | 6.17 | 7.07 |
| Return on Equity (ROE) | -54.98% | -54.98% | -43.23% | -104.47% | -47.38% | -38.97% |
| Return on Assets (ROA) | -34.08% | -34.08% | -28.09% | -52.66% | -26.64% | -25.85% |
| Return on Capital Employed (ROCE) | -58.50% | -58.50% | -34.50% | -141.60% | -63.80% | -43.60% |
| Earnings Yield | -43.42% | -18.71% | -13.31% | -91.15% | -80.84% | -41.06% |
| FCF Yield | -37.07% | -18.01% | -12.55% | -60.11% | -117.35% | -39.72% |
| Buyback Yield / Dilution | -64.53% | -64.53% | -75.31% | -50.29% | -0.91% | -41.79% |